Zhong LiLun, Xu ZhenWen, Peng YingJun, Li SongPeng, Liu An, Lin ZhiDong
Huizhou Hospital of Guangzhou University of Chinese Medicine (Huizhou Hospital of Traditional Chinese Medicine), 516000, Huizhou, PR China.
Huizhou Huicheng Hospital of Traditional Chinese Medicine, 516000, Huizhou, PR China.
Biochem Biophys Rep. 2025 May 15;42:102047. doi: 10.1016/j.bbrep.2025.102047. eCollection 2025 Jun.
Intervertebral disc degeneration (IDD), a primary cause of low back pain, involves complex pathological mechanisms. Current research emphasizes identifying strategies to mitigate degenerative processes and enhance intrinsic disc repair. Emerging evidence highlights the therapeutic potential of icariin (ICA) in promoting disc repair and delaying IDD progression. ICA exerts its effects through multiple mechanisms, including anti-inflammatory actions, oxidative stress mitigation, modulation of bone and collagen metabolism, and inhibition of ferroptosis and pyroptosis. This review synthesizes current research on ICA's therapeutic applications in IDD management.
椎间盘退变(IDD)是腰痛的主要原因,涉及复杂的病理机制。目前的研究重点是确定减轻退变过程和增强椎间盘自身修复的策略。新出现的证据突出了淫羊藿苷(ICA)在促进椎间盘修复和延缓IDD进展方面的治疗潜力。ICA通过多种机制发挥作用,包括抗炎作用、减轻氧化应激、调节骨和胶原蛋白代谢以及抑制铁死亡和焦亡。本综述综合了目前关于ICA在IDD治疗应用方面的研究。